✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

KMS Medisurgi Ltd.

KMSMEDI

Market Cap
₹44 Cr.
P/E
99.65

KMS Medisurgi Ltd.

  • KMS Medisurgi
  • Kretto Syscon
  • Amkay Products

FAQs on KMS Medisurgi Ltd. Shareprice

KMS Medisurgi has given better returns compared to its competitors.
KMS Medisurgi has grown at ~24.83% over the last 2yrs while peers have grown at a median rate of -19.0%

KMS Medisurgi is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of KMS Medisurgi is 99.65, while 3 year average PE is 83.14.
Also latest EV/EBITDA of KMS Medisurgi is 0 while 3yr average is 24.63.

View FAQ's On Business

Growth Table

  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Balance Sheet

  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Cash Flow

  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Quarterly Results

  • KMS Medisurgi Ltd.
  • Kretto Syscon
  • Amkay Products

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on KMS Medisurgi Ltd. Financials

Balance sheet of KMS Medisurgi is strong.
It shouldn't have solvency or liquidity issues.

The net debt of KMS Medisurgi is decreasing.
Latest net debt of KMS Medisurgi is -₹0.33 Crs as of Mar-26.
This is less than Mar-25 when it was -₹0.01 Crs.

No, profit is decreasing.
The profit of KMS Medisurgi is ₹0.44 Crs for Mar 2025, ₹0.45 Crs for Mar 2024 and ₹0.57 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
KMS Medisurgi latest dividend payout ratio is 3.75% and 3yr average dividend payout ratio is 3.42%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech